Skip to main content

Peer Review reports

From: Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study

Original Submission
31 Mar 2022 Submitted Original manuscript
14 Apr 2022 Reviewed Reviewer Report
15 Apr 2022 Reviewed Reviewer Report - Yoshie Morimoto
23 Apr 2022 Author responded Author comments - Guangyuan Lou
3 May 2022 Reviewed Reviewer Report - Yoshie Morimoto
5 May 2022 Reviewed Reviewer Report
10 May 2022 Author responded Author comments - Guangyuan Lou
Resubmission - Version 2
23 Apr 2022 Submitted Manuscript version 2
13 May 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
18 May 2022 Editorially accepted
24 May 2022 Article published 10.1186/s12885-022-09674-2

You can find further information about peer review here.

Back to article page